GLAXOSMITHKLINE, S.A.
Key facts
| Awarded supplier / winner | GLAXOSMITHKLINE, S.A. |
|---|---|
| Registration / LEI number | ES-REG: A28228526 |
| Entity type | Legal entity / organization (large) |
| Country | Spain |
| Confirmed contracts | 1 |
| Awarded volume | €9,155,872.55 (1) |
| Checked | |
| Source | Tenders Electronic Daily (TED) ↗ |
Confirmed contract awards (1)
| Award date | Tenders | Buyer | CPV | Awarded contract amount | Source |
|---|---|---|---|---|---|
| Nov 6, 2026 | Suministro de medicamentos exclusivos con principios activos belimumab, mepolizumab, niraparib y momelotinib del laboratorio glaxosmithkline, s.a | Servicio Murciano de Salud - Junta de Compras | 33652300 | €9,155,872.55 | Tenders Electronic Daily (TED) ↗ |
CPV categories won
| CPV | Confirmed contracts | Award matrices by country (CPV × country) |
|---|---|---|
| 33652300 | 1 | CPV 33000000 × Spain |
Contracting buyers
| Buyer | Country | Confirmed contracts | Awarded volume |
|---|---|---|---|
| Servicio Murciano de Salud - Junta de Compras | Spain | 1 | €9,155,872.55 (1) |
Award dynamics by period
| Period | Confirmed contracts | Awarded volume |
|---|---|---|
2026-11 | 1 | €9,155,872.55 (1) |
Public business contacts
MADRID, 28760, Spain
licitaciones.licitaciones@gsk.com
600593801
Checked:
Sources
The original notice takes precedence. Its status and conditions can change after collection. Hash: 7c08026055a24253
